BCL9 and hepatocellular carcinoma: As we found that BCL9 was a direct miR-1301 target gene that was involved in the miR-1301-mediated malignant phenotypes of HCC cells in vitro, we speculated that miR-1301 downregulation might contribute to BCL9 upregulation in HCC tissues.